Wednesday, October 23, 2024

CopilotIQ and Biofourmis Merge to Launch AI-Driven In-Home Care Platform

Related stories

Why Every Business Needs an Enterprise Virtual Assistant

It goes without saying that the virtual assistant market...

Inflection AI Acquires Boundaryless

Inflection AI announced its acquisition of Boundaryless, a leading...

Universal Robots Unveils Its AI Accelerator

Universal Robots, the Danish collaborative robot (cobot) company, has...

Viz.ai Expands into Lung Disease to Accelerate Diagnosis and Care for Patients

Viz.ai, the leader in AI-powered disease detection and intelligent...

HawkSearch Unveils Enhanced Rapid UI Framework with GenAI-Powered Smart Response

Bridgeline Digital, Inc., a provider of AI-driven marketing technology,...
spot_imgspot_img

CopilotIQ, the health tech company helping older Americans with chronic conditions live longer and healthier lives, and Biofourmis, a global technology-enabled care delivery company, delivering in-home care solutions serving enterprise healthcare customers, announced a strategic merger. The combined company creates the industry’s first AI-driven platform that delivers in-home care across the full spectrum from pre-surgical optimization to acute, post-acute, and chronic care.

For customers, the combination delivers a single vendor that can provide a best-in-class offering across the entire care continuum and creates a ‘single pane of glass’ solution by which enterprise customers will enjoy observability of patients across the care continuum via one technology integration, one security audit, simplified procurement, and a much better patient experience. Hospitals and payors are struggling with an overwhelming level of complexity and cost to manage multiple point solutions required to deliver the necessary suite of home-based care. This combination provides the first solution that solves these problems.

“Our mission is to redefine the future of healthcare delivery, by extending care to the comfort of patients’ homes, and driving improved health outcomes, at the lowest possible cost to the system,” said David Koretz, CEO of CopilotIQ and Biofourmis, the newly combined entity. “This merger is a major step toward realizing our vision of transforming healthcare from reactive treatment to proactive prevention, and from generalized to deeply personalized, data-driven care.”

Also Read: Sapio Sciences Enhances Bioanalysis LIMS and ELN with Advanced Immunogenicity Capabilities

Biofourmis’ capabilities in supporting health systems, payors, and life sciences companies’ delivery of complex care for their patients in the home with FDA-cleared algorithms and technology will be expanded further upstream and downstream when combined with CopilotIQ. The combined company will unlock coordinated, convenient, and cost-effective care for patients managing chronic conditions. Further, CopilotIQ’s transformative software suite for driving patient engagement, improving clinician efficiency, and delivering clinical personalization, will be integrated across Biofourmis’ acute and post-acute offerings.

SOURCE: Businesswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img